190 related articles for article (PubMed ID: 26540726)
1. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Cullere X; Plovie E; Bennett PM; MacRae CA; Mayadas TN
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14284-9. PubMed ID: 26540726
[TBL] [Abstract][Full Text] [Related]
2. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
3. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X
Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093
[TBL] [Abstract][Full Text] [Related]
4. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.
Zhou Z; Rawnsley DR; Goddard LM; Pan W; Cao XJ; Jakus Z; Zheng H; Yang J; Arthur JS; Whitehead KJ; Li D; Zhou B; Garcia BA; Zheng X; Kahn ML
Dev Cell; 2015 Jan; 32(2):168-80. PubMed ID: 25625206
[TBL] [Abstract][Full Text] [Related]
5. ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.
Rosen JN; Sogah VM; Ye LY; Mably JD
Dev Biol; 2013 Apr; 376(1):74-85. PubMed ID: 23328253
[TBL] [Abstract][Full Text] [Related]
6. Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3.
Wang X; Hou Y; Deng K; Zhang Y; Wang DC; Ding J
Structure; 2015 Jun; 23(6):1087-96. PubMed ID: 25982527
[TBL] [Abstract][Full Text] [Related]
7. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
8. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
10. Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex.
Fisher OS; Deng H; Liu D; Zhang Y; Wei R; Deng Y; Zhang F; Louvi A; Turk BE; Boggon TJ; Su B
Nat Commun; 2015 Aug; 6():7937. PubMed ID: 26235885
[TBL] [Abstract][Full Text] [Related]
11. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
Yoruk B; Gillers BS; Chi NC; Scott IC
Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
[TBL] [Abstract][Full Text] [Related]
12. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
[TBL] [Abstract][Full Text] [Related]
13. Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation.
Yang X; Wu ST; Gao R; Wang R; Wang Y; Dong Z; Wang L; Qi C; Wang X; Schmitz ML; Liu R; Han Z; Wang L; Zheng X
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36692953
[TBL] [Abstract][Full Text] [Related]
14. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.
Zawistowski JS; Stalheim L; Uhlik MT; Abell AN; Ancrile BB; Johnson GL; Marchuk DA
Hum Mol Genet; 2005 Sep; 14(17):2521-31. PubMed ID: 16037064
[TBL] [Abstract][Full Text] [Related]
15. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
[TBL] [Abstract][Full Text] [Related]
16. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.
Voss K; Stahl S; Hogan BM; Reinders J; Schleider E; Schulte-Merker S; Felbor U
Hum Mutat; 2009 Jun; 30(6):1003-11. PubMed ID: 19370760
[TBL] [Abstract][Full Text] [Related]
17. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
18. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
[TBL] [Abstract][Full Text] [Related]
19. The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity.
Lisowska J; Rödel CJ; Manet S; Miroshnikova YA; Boyault C; Planus E; De Mets R; Lee HH; Destaing O; Mertani H; Boulday G; Tournier-Lasserve E; Balland M; Abdelilah-Seyfried S; Albiges-Rizo C; Faurobert E
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 30030370
[TBL] [Abstract][Full Text] [Related]
20. Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.
Choi JP; Foley M; Zhou Z; Wong WY; Gokoolparsadh N; Arthur JS; Li DY; Zheng X
PLoS One; 2016; 11(8):e0160833. PubMed ID: 27513872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
